A co-culture system with an organotypic lung slice and an immortal alveolar macrophage cell line to quantify silica-induced inflammation

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Hofmann, Falk ^a   Bläsche, Robert ^a   Kasper, Michael ^a   Barth, Kathrin ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CAVEOLIN 2; CELL PROTEIN; INTERLEUKIN 6; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 1; PROTEIN T1 ALPHA; SILICA NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; NANOPARTICLE; P2RX7 PROTEIN, MOUSE; PURINERGIC P2X7 RECEPTOR; SILICON DIOXIDE;

ANIMAL TISSUE; ARTICLE; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG SLICE; MALE; MOUSE; NONHUMAN; PNEUMONIA; WILD TYPE; ANIMAL; C57BL MOUSE; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; EPITHELIUM CELL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG; METABOLISM; PATHOLOGY; PROCEDURES;

MUS;

ANIMALS; CAVEOLIN 1; CAVEOLIN 2; CELL LINE; CELL SURVIVAL; COCULTURE TECHNIQUES; CYTOKINES; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE, INBRED C57BL; NANOPARTICLES; PROTEIN KINASE C BETA; RECEPTORS, PURINERGIC P2X7; SILICON DIOXIDE;

EID: 84922352568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117056     Document Type: Article

References (55)

1. Antonini JM, Roberts JR, Yang HM, Barger MW, Ramsey D, et al. (2000) Effect of silica inhalation on the pulmonary clearance of a bacterial pathogen in Fischer 344 rats. Lung 178: 341-350. doi: 10.1007/s004080000038 PMID: 11361057
2. Fujimura N (2000) Pathology and pathophysiology of pneumoconiosis. Curr Opin Pulm Med 6: 140-144. doi: 10.1097/00063198-200003000-00010 PMID: 10741774
3. Huaux F (2007) New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol 7: 168-173. doi: 10.1097/ACI.0b013e32802bf8a5 PMID: 17351471
4. Vanhee D, Gosset P, Boitelle A, Wallaert B, Tonnel AB (1995) Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. Eur Respir J 8: 834-842. PMID: 7656959
5. Li XY, Brown D, Smith S, MacNee W, Donaldson K (1999) Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. Inhal Toxicol 11: 709-731. doi: 10.1080/089583799196826 PMID: 10477444
6. Nemmar A, Hoylaerts MF, Hoet PH, Vermylen J, Nemery B (2003) Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol 186: 38-45. doi: 10.1016/S0041-008X(02)00024-8 PMID: 12583991
7. Zhang Q, Kusaka Y, Zhu X, Sato K, Mo Y, et al. (2003) Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J Occup Health 45: 23-30. doi: 10.1539/joh.45.23 PMID: 14605425
8. Chen M, von Mikecz A (2005) Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp Cell Res 305: 51-62. doi: 10.1016/j.yexcr.2004.12.021 PMID: 15777787
9. Eom HJ, Choi J (2009) Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B. Toxicol In Vitro 23: 1326-1332. doi: 10.1016/j.tiv.2009.07.010 PMID: 19602432
10. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Arimori A, et al. (2010) Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. Pharmazie 65: 199-201. PMID: 20383940
11. Shi Y, Yadav S, Wang F, Wang H (2010) Endotoxin promotes adverse effects of amorphous silica nanoparticles on lung epithelial cells in vitro. J Toxicol Environ Health A 73: 748-756. doi: 10.1080/15287391003614042 PMID: 20391117
12. Ye Y, Liu J, Chen M, Sun L, Lan M (2010) In vitro toxicity of silica nanoparticles in myocardial cells. Environ Toxicol Pharmacol 29: 131-137. doi: 10.1016/j.etap.2009.12.002 PMID: 21787594
13. Lin W, Huang YW, Zhou XD, Ma Y (2006) In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 217: 252-259. doi: 10.1016/j.taap.2006.10.004 PMID: 17112558
14. Wottrich R, Diabate S, Krug HF (2004) Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. Int J Hyg Environ Health 207: 353-361. doi: 10.1078/1438-4639-00300 PMID: 15471099
15. Ye Y, Liu J, Xu J, Sun L, Chen M, et al. (2010) Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. Toxicol In Vitro 24: 751-758. doi: 10.1016/j.tiv.2010.01.001 PMID: 20060462
16. Yu K, Grabinski C, Schrand A, Murdock R, Wang W, et al. (2009) Toxicity of amorphous silica nanoparticles in mouse keratinocytes. Journal of Nanoparticle Research 11: 15-24. doi: 10.1007/s11051-008-9417-9
17. Herold S, Gabrielli NM, Vadasz I (2013) Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 305: L665-681. doi: 10.1152/ajplung.00232.2013 PMID: 24039257
18. Wilson MS, Wynn TA (2009) Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2: 103-121. doi: 10.1038/mi.2008.85 PMID: 19129758
19. Moore BB, Hogaboam CM (2008) Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294: L152-160. doi: 10.1152/ajplung.00313.2007 PMID: 17993587
20. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, et al. (2004) Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279: 51630-51646. doi: 10.1074/jbc.M409214200 PMID: 15355971
21. Jin Y, Lee SJ, Minshall RD, Choi AM (2011) Caveolin-1: a critical regulator of lung injury. Am J Physiol Lung Cell Mol Physiol 300: L151-160. doi: 10.1152/ajplung.00170.2010 PMID: 21097526
22. Jin Y, Kim HP, Chi M, Ifedigbo E, Ryter SW, et al. (2008) Deletion of caveolin-1 protects against oxidative lung injury via up-regulation of heme oxygenase-1. Am J Respir Cell Mol Biol 39: 171-179. doi: 10.1165/rcmb.2007-0323OC PMID: 18323531
23. Jin Y, Kim HP, Cao J, Zhang M, Ifedigbo E, et al. (2009) Caveolin-1 regulates the secretion and cytoprotection of Cyr61 in hyperoxic cell death. Faseb j 23: 341-350. doi: 10.1096/fj.08-108423 PMID: 18801924
24. Zhang M, Lin L, Lee SJ, Mo L, Cao J, et al. (2009) Deletion of caveolin-1 protects hyperoxia-induced apoptosis via survivin-mediated pathways. Am J Physiol Lung Cell Mol Physiol 297: L945-953. doi: 10.1152/ajplung.00081.2009 PMID: 19767411
25. Kasper M, Barth K (2009) Bleomycin and its role in inducing apoptosis and senescence in lung cells-modulating effects of caveolin-1. Curr Cancer Drug Targets 9: 341-353. doi: 10.2174/156800909788166501 PMID: 19442053
26. Mungunsukh O, Griffin AJ, Lee YH, Day RM (2010) Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 298: L696-703. doi: 10.1152/ajplung.00322.2009 PMID: 20154224
27. Odajima N, Betsuyaku T, Nasuhara Y, Nishimura M (2007) Loss of caveolin-1 in bronchiolization in lung fibrosis. J Histochem Cytochem 55: 899-909. doi: 10.1369/jhc.7A7203.2007 PMID: 17478448
28. Wallach-Dayan SB, Izbicki G, Cohen PY, Gerstl-Golan R, Fine A, et al. (2006) Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol 290: L790-l796. doi: 10.1152/ajplung.00300.2004 PMID: 16306138
29. Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, et al. (2006) Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203: 2895-2906. doi: 10.1084/jem.20061536 PMID: 17178917
30. Barth K, Weinhold K, Guenther A, Linge A, Gereke M, et al. (2008) Characterization of the molecular interaction between caveolin-1 and the P2X receptors 4 and 7 in E10 mouse lung alveolar epithelial cells. Int J Biochem Cell Biol 40: 2230-2239. doi: 10.1016/j.biocel.2008.03.001 PMID: 18407780
31. Riteau N, Baron L, Villeret B, Guillou N, Savigny F, et al. (2012) ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation. Cell Death Dis 3: e403. doi: 10.1038/cddis.2012.144 PMID: 23059822
32. Moncao-Ribeiro LC, Faffe DS, Santana PT, Vieira FS, da Graca CL, et al. (2014) P2X7 receptor modulates inflammatory and functional pulmonary changes induced by silica. PLoS One 9: e110185. doi: 10.1371/journal.pone.0110185 PMID: 25310682
33. Wiley JS, Gu BJ (2012) A new role for the P2X7 receptor: a scavenger receptor for bacteria and apoptotic cells in the absence of serum and extracellular ATP. Purinergic Signal 8: 579-586. doi: 10.1007/s11302-012-9308-5 PMID: 22476940
34. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, et al. (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276: 125-132. doi: 10.1074/jbc.M006781200 PMID: 11016935
35. Herzog CR, Soloff EV, McDoniels AL, Tyson FL, Malkinson AM, et al. (1996) Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Oncogene 13: 1885-1891. PMID: 8934534
36. Palleroni AV, Varesio L, Wright RB, Brunda MJ (1991) Tumoricidal alveolar macrophage and tumor infiltrating macrophage cell lines. Int J Cancer 49: 296-302. doi: 10.1002/ijc.2910490226 PMID: 1879973
37. Held HD, Martin C, Uhlig S (1999) Characterization of airway and vascular responses in murine lungs. Br J Pharmacol 126: 1191-1199. doi: 10.1038/sj.bjp.0702394 PMID: 10205008
38. Ebeling G, Blasche R, Hofmann F, Augstein A, Kasper M, et al. (2014) Effect of P2X7 Receptor Knockout on AQP-5 Expression of Type I Alveolar Epithelial Cells. PLoS One 9: e100282. doi: 10.1371/journal.pone.0100282 PMID: 24941004
39. Dieckmann-Schuppert A, Schnittler HJ (1997) A simple assay for quantification of protein in tissue sections, cell cultures, and cell homogenates, and of protein immobilized on solid surfaces. Cell Tissue Res 288: 119-126. doi: 10.1007/s004410050799 PMID: 9042779
40. Linge A, Morishima N, Kasper M, Barth K (2007) Bleomycin induces caveolin-1 and -2 expression in epithelial lung cancer A549 cells. Anticancer Res 27: 1343-1351. PMID: 17593629
41. Kasper M, Seidel D, Knels L, Morishima N, Neisser A, et al. (2004) Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdCl2 and TGF-beta1. Histochem Cell Biol 121: 131-140. doi: 10.1007/s00418-003-0612-6 PMID: 14752665
42. Kasper M, Fehrenbach H (2000) Immunohistochemical evidence for the occurrence of similar epithelial phenotypes during lung development and radiation-induced fibrogenesis. Int J Radiat Biol 76: 493-501. doi: 10.1080/095530000138493 PMID: 10815629
43. McElroy MC, Kasper M (2004) The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur Respir J 24: 664-673. doi: 10.1183/09031936.04.00096003 PMID: 15459148
44. Bläsche R, Ebeling G, Perike S, Weinhold K, Kasper M, et al. (2012) Activation of P2X7R and downstream effects in bleomycin treated lung epithelial cells. Int J Biochem Cell Biol 44: 514-524. doi: 10.1016/j.biocel.2011.12.003 PMID: 22192844
45. Gilberti RM, Joshi GN, Knecht DA (2008) The phagocytosis of crystalline silica particles by macrophages. Am J Respir Cell Mol Biol 39: 619-627. doi: 10.1165/rcmb.2008-0046OC PMID: 18556590
46. Rastrick J, Birrell M (2014) The role of the inflammasome in fibrotic respiratory diseases. Minerva Med 105: 9-23. PMID: 24572449
47. Kojima S, Negishi Y, Tsukimoto M, Takenouchi T, Kitani H, et al. (2014) Purinergic signaling via P2X7 receptor mediates IL-1beta production in Kupffer cells exposed to silica nanoparticle. Toxicology 321: 13-20. doi: 10.1016/j.tox.2014.03.008 PMID: 24685903
48. Koslowski R, Dobbs LG, Wenzel KW, Schuh D, Muller M, et al. (1998) Loss of immunoreactivity for RTI40, a type I cell-specific protein in the alveolar epithelium of rat lungs with bleomycin-induced fibrosis. Eur Respir J 12: 1397-1403. doi: 10.1183/09031936.98.12061397 PMID: 9877498
49. Kasper M, Koslowski R, Luther T, Schuh D, Muller M, et al. (1995) Immunohistochemical evidence for loss of ICAM-1 by alveolar epithelial cells in pulmonary fibrosis. Histochem Cell Biol 104: 397-405. doi: 10.1007/BF01458134 PMID: 8574890
50. Gabazza EC, Kasper M, Ohta K, Keane M, D'Alessandro-Gabazza C, et al. (2004) Decreased expression of aquaporin-5 in bleomycin-induced lung fibrosis in the mouse. Pathol Int 54: 774-780. doi: 10.1111/j.1440-1827.2004.01754.x PMID: 15482567
51. Englert JM, Hanford LE, Kaminski N, Tobolewski JM, Tan RJ, et al. (2008) A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 172: 583-591. doi: 10.2353/ajpath.2008.070569 PMID: 18245812
52. Kasper M, Reimann T, Hempel U, Wenzel KW, Bierhaus A, et al. (1998) Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis. Histochem Cell Biol 109: 41-48. doi: 10.1007/s004180050200 PMID: 9452954
53. Barth K, Weinhold K, Guenther A, Young MT, Schnittler H, et al. (2007) Caveolin-1 influences P2X7 receptor expression and localization in mouse lung alveolar epithelial cells. Febs j 274: 3021-3033. doi: 10.1111/j.1742-4658.2007.05830.x PMID: 17498208
54. Rao KM, Porter DW, Meighan T, Castranova V (2004) The sources of inflammatory mediators in the lung after silica exposure. Environ Health Perspect 112: 1679-1686. doi: 10.1289/ehp.7295 PMID: 15579413
55. Green FH, Vallyathan V, Hahn FF (2007) Comparative pathology of environmental lung disease: an overview. Toxicol Pathol 35: 136-147. doi: 10.1080/01926230601132055 PMID: 17325982